Syndax Pharmaceuticals SNDX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's accounts payable?
- Syndax Pharmaceuticals (SNDX) reported accounts payable of $10.84M in Q1 2026.
- How has Syndax Pharmaceuticals's accounts payable changed year-over-year?
- Syndax Pharmaceuticals's accounts payable increased by 7.9% year-over-year, from $10.05M to $10.84M.
- What is the long-term trend for Syndax Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's accounts payable has grown at a 36.4% compound annual growth rate (CAGR), from $3.51M to $16.58M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.